IonQ (IONQ) to purchase cybersecurity firm Elisity in a transaction that is valued at up to USD 1.3bln, reports WSJ
Every headline is on the live feed 20 minutes before this site.
IonQ (IONQ) to purchase cybersecurity firm Elisity in a transaction that is valued at up to USD 1.3bln, reports WSJ
China's VP met with Apple (AAPL) Chairman in Beijing, Xinhua reports
Bristol Myers Squibb (BMY) announces Phase 3 ACTION-1 for RYZ101 met the primary endpoint
On the Newsquawk feed at , 20 minutes before this page.
Context
Acquisitions of this kind by a high-multiple, pre-profit quantum computing name tend to follow a familiar pattern: the buyer uses equity or cash raised on a rich valuation to bolt on adjacent capability, and the initial reaction in the acquirer has historically hinged on the funding mix rather than the strategic logic. The 'up to' construction matters, as it implies an earnout or milestone component, which in past deals of this structure has softened the immediate dilution read while shifting the debate to execution risk and integration. The stated size is large relative to what a cybersecurity asset of this profile would typically command, which raises the usual questions about whether the strategic rationale, presumably pairing quantum-safe security with the core compute story, justifies the premium or whether it reads as multiple-driven empire building. Worth watching are the formal company confirmation versus the press report, the consideration split between cash and stock, and any detail on the earnout triggers, since stock-funded deals in richly valued names have tended to pressure the acquirer on announcement and re-rate only once integration evidence accumulates. Precedent in the quantum space is thin, so the read-through to peers has historically been more about sentiment toward the sector's capital deployment than any direct comparable.
Related headlines
- China's VP met with Apple (AAPL) Chairman in Beijing, Xinhua reports24 min ago
- Bristol Myers Squibb (BMY) announces Phase 3 ACTION-1 for RYZ101 met the primary endpoint24 min ago
- Bristol Myers Squibb (BMY) announces Phase 3 ALOFT-IPF trial evaluating admilparant in adults with idiopathic pulmonary fibrosis met primary endpoint30 min ago
- NHTSA open a defect petition into around 1000 Tesla (TSLA) Robotaxi vehicles; petition alleges that the subject vehicles exceed posted speed limits in active school zones2 hours ago
- Intel (INTC) CEO says quantum computing will become mainstream within three to five years4 hours ago
- Newsquawk Weekly US Earnings Estimates: 12-16th October 2026: Earnings season begins with big banks the highlights2 days ago
- Google (GOOGL) is preparing to publicly roll out its new Gemini 4 model, internally known as Argon, reports Business Insider citing sources; Most recently, employees have been trying a new version of Gemini 4 internally named Carbon2 days ago
- Hunterbrook says Meta's (META) Muse growth slows as downloads fall2 days ago
- White House reportedly to let Trump beef import plan expire in November, reports Politico2 days ago
- Delta (DAL) expects operational recovery performance to "further improve" through year-end and into 2027, despite a challenging summer operating environment 2 days ago
- US EQUITY OPEN: Stocks open higher with Nasdaq leading gains2 days ago
- Newsquawk Daily US Equity Opening News - AAPL cuts October iPhone 18 Pro component orders; SPCX agrees USD 8bln spectrum acquisition2 days ago
- US BROKER MOVES: CBOE upgraded at Morgan Stanley; DD downgraded at JPM2 days ago
- Micron (MU) says it plans to construct new fabrication facilities and/or ramp production at existing fabrication facilities to increase supply in to respond to a significant increase in demand for memory products2 days ago
- US PRE-MARKET MOVERS: AAPL, SPCX, DAL, HUM/ALHC, LITE2 days ago
- GlobalFoundries (GFS) unveils FDX Fusion FD-SOI platform for physical AI2 days ago
- Netflix (NFLX) restructuring to impact roughly 5% employees and could be announces as early as next week, Puck reports citing sources2 days ago
- Delta (DAL) CEO says it was a challenging quarter due to 60% rise in fuel costs, but maintained overall profitability; prices will rise further in Q43 days ago
- Johnson & Johnson (JNJ) says 2-year ICOTYDE data in moderate-to-severe plaque psoriasis showed sustained efficacy through week 1123 days ago
- AT&T (T) offers up to USD 1,200 off iPhone duo with eligible trade-in3 days ago
The feed had this first.
Use the Platform